1. Home
  2. IMMP vs PAL Comparison

IMMP vs PAL Comparison

Compare IMMP & PAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • PAL
  • Stock Information
  • Founded
  • IMMP 1987
  • PAL 2023
  • Country
  • IMMP Australia
  • PAL United States
  • Employees
  • IMMP N/A
  • PAL N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • PAL
  • Sector
  • IMMP Health Care
  • PAL
  • Exchange
  • IMMP Nasdaq
  • PAL NYSE
  • Market Cap
  • IMMP 221.2M
  • PAL 219.0M
  • IPO Year
  • IMMP N/A
  • PAL 2024
  • Fundamental
  • Price
  • IMMP $1.72
  • PAL $7.13
  • Analyst Decision
  • IMMP Buy
  • PAL Strong Buy
  • Analyst Count
  • IMMP 1
  • PAL 3
  • Target Price
  • IMMP $7.00
  • PAL $16.00
  • AVG Volume (30 Days)
  • IMMP 98.8K
  • PAL 162.1K
  • Earning Date
  • IMMP 02-27-2025
  • PAL 08-11-2025
  • Dividend Yield
  • IMMP N/A
  • PAL N/A
  • EPS Growth
  • IMMP N/A
  • PAL N/A
  • EPS
  • IMMP N/A
  • PAL N/A
  • Revenue
  • IMMP $3,019,249.00
  • PAL $336,060,548.00
  • Revenue This Year
  • IMMP $50.37
  • PAL $76.05
  • Revenue Next Year
  • IMMP N/A
  • PAL $14.47
  • P/E Ratio
  • IMMP N/A
  • PAL N/A
  • Revenue Growth
  • IMMP 24.11
  • PAL N/A
  • 52 Week Low
  • IMMP $1.32
  • PAL $6.55
  • 52 Week High
  • IMMP $2.72
  • PAL $21.01
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 50.07
  • PAL N/A
  • Support Level
  • IMMP $1.53
  • PAL N/A
  • Resistance Level
  • IMMP $1.71
  • PAL N/A
  • Average True Range (ATR)
  • IMMP 0.07
  • PAL 0.00
  • MACD
  • IMMP 0.01
  • PAL 0.00
  • Stochastic Oscillator
  • IMMP 72.41
  • PAL 0.00

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About PAL PROFICIENT AUTO LOGISTICS INC

Proficient Auto Logistics Inc is a non-union, specialized freight company focused on providing auto transportation and logistics services. The company operates auto transportation fleets in North America based upon information obtained from the Auto Haulers Association of America, utilizing auto transport vehicles and trailers daily, including Company-owned transport vehicles and trailers. The reportable revenue categories of the company are Truckload and Brokerage. The company derives maximum revenue from the brokerage segment that retains the customer relationship, including billing and collection, and outsources the transportation of the loads to third-party carriers.

Share on Social Networks: